Microbiome-Directed Bioactive Strategies in Skin Aging: Mechanistic Insights and Precision Nanocarrier Delivery
Beatrice Bălăceanu-Gurău1, Ina Sotiri2, Patricija Girštautė3
1Ph.D. Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Abstract:
Skin aging is a multidimensional biological process driven by intrinsic chronological changes, exposomal stress, endocrine-metabolic shifts, extracellular matrix remodeling, inflammaging, oxidative injury, barrier impairment, and microbiome dysbiosis. This review integrates current evidence on the endocrine-microbiome-skin axis and evaluates microbiome-directed bioactive strategies for preserving cutaneous homeostasis during aging. Particular attention is given to probiotics, prebiotics, postbiotics, synbiotics, phytoestrogens, polyphenols, bioactive peptides, antioxidants, mitochondrial protectors, adaptogens, and metabolic modulators. Their mechanisms are discussed in relation to collagen homeostasis, mitochondrial function, lipid barrier integrity, immune regulation, microbial metabolite signaling, and systemic endocrine-metabolic status. The review also examines advanced delivery platforms, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanocarriers, nanoemulsions, encapsulated microbiome-active systems, and stimuli-responsive carriers, emphasizing their potential to improve compound stability, skin retention, controlled release, and target-site precision. Translational limitations are critically addressed, including strain and formulation specificity, insufficient long-term safety data, incomplete nanocarrier toxicology, regulatory ambiguity, and the need for personalization according to hormonal, metabolic, and microbiome profiles. Overall, microbiome-directed bioactive compounds combined with precision delivery systems represent a promising, but still evolving, strategy for delaying skin aging and restoring cutaneous homeostasis.
Insights
Targeting the skin microbiome with bioactive compounds and advanced delivery systems shows promise for delaying skin aging and restoring skin health. This approach addresses key aging factors like inflammation and oxidative stress.
Area of Science:
- Dermatology and Aging Research
- Microbiome Science
- Biotechnology
Background:
- Skin aging is a complex process influenced by intrinsic factors, environmental exposures, and physiological changes.
- The endocrine-microbiome-skin axis plays a crucial role in maintaining skin homeostasis during aging.
- Dysbiosis and impaired skin barrier function are key hallmarks of aged skin.
Purpose of the Study:
- To review the current evidence on the endocrine-microbiome-skin axis in aging.
- To evaluate microbiome-directed bioactive strategies for skin aging.
- To examine advanced delivery platforms for enhancing bioactive compound efficacy.
Main Methods:
- Literature review integrating evidence on the endocrine-microbiome-skin axis.
- Analysis of microbiome-directed bioactives (probiotics, prebiotics, etc.) and their mechanisms.
- Evaluation of advanced delivery systems (liposomes, nanoparticles, etc.).
Main Results:
- Microbiome-directed bioactives influence collagen homeostasis, mitochondrial function, barrier integrity, and immune regulation.
- Advanced delivery platforms enhance compound stability, skin retention, and targeted release.
- Key mechanisms involve microbial metabolite signaling and systemic endocrine-metabolic status.
Conclusions:
- Microbiome-directed bioactive compounds combined with precision delivery systems offer a promising strategy for mitigating skin aging.
- Further research is needed to address translational limitations, including personalization and long-term safety.
- This evolving strategy aims to delay skin aging and restore cutaneous homeostasis.
Related Concept Videos
Microbial Corrosion
Site-Targeted Drug Delivery Systems: Polymeric Carriers
The Skin Microbiota
Renewal of Skin Epidermal Stem Cells
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Clinical Applications of Epidermal Stem Cells
